Handelsavisen
prelaunch
TO
TOI.V Software

Topicus.com Inc

$101,99
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
15,0 %
ROE
8,8 %
Net margin
2,7 %
Debt / equity
1,67
Beta
52w range
Volume
5,5k
Day range
$4,53–$4,74
Prev close
$4,71
Open
$4,74
Next earnings
Ex-dividend
TR 1Y
About

Topicus.com Inc provides software solutions, primarily generating revenue through software sales and services.

Business. Topicus.com Inc (TOI.V) is a software company operating within the Software & IT Services sector. The firm generates revenue through a subscription-based model, aligning with industry standards for tracking metrics such as annual recurring revenue and net revenue retention. Specific details regarding operating segments, headquarters location, and primary exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target145,00

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
145,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
53
composite score
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
not yet wired
Profitability
8,8 %
return on equity
Quality
59
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning TOI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care+0,7 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology · THIS SECTOR−0,3 %+6,6 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to TOI.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Peers
    • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
    • EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score53 / 100
    Composite score 0-100 · Data quality 0,59
    Data quality0,59 / 1.00

    Synthesis

    Business

    Topicus.com Inc (TOI.V) is a software company operating within the Software & IT Services sector. The firm generates revenue through a subscription-based model, aligning with industry standards for tracking metrics such as annual recurring revenue and net revenue retention. Specific details regarding operating segments, headquarters location, and primary exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

    Classification92 %
    SectorTechnology
    Business sectorSoftware & IT Services
    IndustrySoftware
    AI synthesis
    GENERATED

    Topicus.com Inc has a debt-to-equity ratio of 1.67, indicating a capital structure that is moderately leveraged, with liabilities exceeding equity by a significant margin. The company’s liquidity position is assessed as medium, with a current ratio of 0.62, suggesting limited short-term liquidity to cover immediate obligations. Free cash flow of EUR 263.69 million supports operational flexibility, though capital expenditures were negative at EUR -10.65 million, indicating no significant reinvestment in physical assets.

    Profitability metrics show a return on equity (ROE) of 8.81%, which is relatively strong, but return on assets (ROA) of 1.66% is weak, suggesting underutilization of total assets to generate returns. Operating income of EUR 233.21 million and a gross profit margin of 89.87% indicate strong core business performance, though net income of EUR 41.76 million is relatively modest given the scale of operations.

    The company does not disclose segment or geographic revenue breakdowns in the provided data, so it is not possible to assess revenue concentration or geographic exposure.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no specific growth or decline percentages provided in the outlook. Analysts have assigned a mean price target of EUR 145.00, with a median of EUR 145.00 and a consensus recommendation of 2.00 (Buy).

    Risk factors include a medium liquidity risk due to the current ratio of 0.62 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure expected, and no recent issuance or ATM/shelf disclosures reported.

    No recent filings or transcripts are provided in the input data to inform recent events or strategic shifts.

    Key takeaways
    • Topicus.com Inc has a strong gross profit margin but a weak return on assets, indicating inefficiencies in asset utilization.
    • The company’s capital structure is moderately leveraged, with a debt-to-equity ratio of 1.67.
    • Free cash flow of EUR 263.69 million provides some operational flexibility, but capital expenditures are minimal.
    • Analysts have a positive outlook, with a mean price target of EUR 145.00 and a consensus Buy recommendation.
    • Liquidity risk is medium, and dilution risk is low with no near-term pressure.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $101,99
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $473.8M
    Net cash
    -$790.9M
    Current ratio
    0.6
    Debt / equity
    1.7
    ROA
    1.7%
    ROE
    8.8%
    Cash conversion
    988.0%
    CapEx / revenue
    -0.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Application Software
    low · llm_fanout_v2
    SaaS / Cloud Software
    low · llm_fanout_v2
    Software Licensing
    low · llm_fanout_v2
    Software as a Service
    low · llm_fanout_v2

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryHealthcare Providers & Services16,0B node revenueOPCH 35,3%PACS 33,0%PRVA 13,3%SHC 7,3%NUTX 5,5%TOI 3,1%VMD 1,7%JYNT 0,3%Other 0,5%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)TOI 3,1% · rank #6 of 16

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison7 peers · vs TOI · multiples and returns
    OP
    OPCH
    Option Care Health Inc
    $21,32
    3,3B USD
    P/E
    15,9x
    vs self
    Div yield
    vs self
    ROE
    15,7 %
    +63,8 vs self
    PA
    PACS
    Pacs Group Inc
    $38,00
    P/E
    vs self
    Div yield
    vs self
    ROE
    20,2 %
    +68,4 vs self
    PR
    PRVA
    Privia Health Group Inc
    $27,19
    3,4B USD
    P/E
    123,6x
    vs self
    Div yield
    vs self
    ROE
    3,1 %
    +51,3 vs self
    SH
    SHC
    Sotera Health Co
    $17,94
    5,1B USD
    P/E
    57,5x
    vs self
    Div yield
    vs self
    ROE
    12,9 %
    +61,0 vs self
    NU
    NUTX
    NUTEX HEALTH INC.
    $193,54
    1,4B USD
    P/E
    9,7x
    vs self
    Div yield
    vs self
    ROE
    29,2 %
    +77,4 vs self
    VM
    VMD
    Viemed Healthcare Inc
    $12,13
    466,8M USD
    P/E
    24,4x
    vs self
    Div yield
    vs self
    ROE
    10,5 %
    +58,7 vs self
    JY
    JYNT
    Joint Corp
    $9,05
    129,0M USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -15,5 %
    +32,6 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 44 %
    EPS
    Consensus EPS
    2,29
    Predicted surprise
    -0,01
    Beat probability
    44 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio -0,03 · as of 2026-05-25 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate2,29
    Revenueno estimateno estimate1,8B EUR
    Operating incomeno estimateno estimate286,0M EUR
    Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-07-07

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy0
    Buy3
    Hold0
    Sell0
    Strong sell0
    12-month price target$145,00 · Median $145,00
    Low $140,00High $150,00
    Operating income · consensus286,0M EUR
    EPS surprise
    −78,1 %
    reported vs consensus · miss
    Revenue surprise
    −13,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$140,00
    Mean$145,00
    Median$145,00
    High$150,00
    Spot$101,99
    +42.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin15,0 %Above P75
    Net Margin2,7 %Above median
    ROE8,8 %Above median
    Capex / Rev-0,7 %Above median
    D/E1,67Bottom quartile
    Cash Conv9,88Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Topicus.com Inc Market data — financials · 2026-05-29
    • Topicus.com Inc Market data — analyst estimates · 2026-05-29

    Ownership & reference

    Leadership

    • Robin van PoeljeChairman of the Board, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    TOI.VCanonical
    — · USD

    Intel & risk

    PredictorBeat prob44 %Surprise-0,01Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    TOIMSFTCRMNOWSoftware
    This companyPeerSector

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-23 00:00 UTCINSIDER3 insider transactions — 2026-06 · $273k gross
    2026-06-23 00:00 UTCINSIDER3 insider transactions — 2026-06 · $273k gross
    2026-06-23INSIDERChernett Jorey bought 18.0k sh — 10% owner ~$90k
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged
    2026-06-18FILINGFORM 8-K →
    2026-06-08INSIDERPodnos Yale sold 23.5k sh — Chief Medical Officer ~$126k
    2026-06-04INSIDERChernett Jorey bought 12.0k sh — 10% owner ~$57k
    2026-05-22FILINGFORM 8-K →
    2026-05-21 00:00 UTCINSIDER6 insider transactions — 2026-05 · net buy $161k
    2026-05-21 00:00 UTCINSIDER6 insider transactions — 2026-05 · net buy $161k
    2026-05-21INSIDERPodnos Yale transacted 1.8k sh — Chief Medical Officer ~$8k
    2026-05-21INSIDERVirnich Daniel transacted 23.1k sh — Chief Executive Officer ~$103k
    2026-05-21INSIDERCarter Robert Ross transacted 1.6k sh — Chief Financial Officer ~$7k
    2026-05-20INSIDERChernett Jorey bought 33.5k sh — 10% owner ~$136k
    2026-05-19INSIDERChernett Jorey bought 5.0k sh — 10% owner ~$20k
    2026-05-19INSIDERChernett Jorey bought 30.0k sh — 10% owner ~$123k
    2026-05-07FILINGFORM 8-K →
    2026-05-07FILING10-Q filing →
    2026-04-30FILINGDEF 14A filing →
    2026-04-16 00:00 UTCINSIDER3 insider transactions — 2026-04 · net sell $273k
    2026-04-16 00:00 UTCINSIDER3 insider transactions — 2026-04 · net sell $273k
    2026-04-16INSIDERKaushal Mohit sold 38.4k sh — Director ~$135k
    2026-04-14INSIDERKaushal Mohit sold 57.3k sh — Director ~$201k
    2026-04-09INSIDERChernett Jorey bought 20.0k sh — 10% owner ~$62k
    2026-03-27 00:00 UTCINSIDER15 insider transactions — 2026-03 · net buy $237k
    2026-03-27 00:00 UTCINSIDER15 insider transactions — 2026-03 · net buy $237k
    2026-03-27INSIDERPodnos Yale transacted 16.2k sh — Chief Medical Officer ~$50k
    2026-03-27INSIDERLangsam Jeffrey transacted 70.3k sh — Chief Clinical Officer
    2026-03-27INSIDEREngland Kristin transacted 55.7k sh — Chief Administrative Officer
    2026-03-27INSIDERPodnos Yale transacted 66.4k sh — Chief Medical Officer
    2026-03-27INSIDERCarter Robert Ross transacted 202.9k sh — Chief Financial Officer
    2026-03-27INSIDERCarter Robert Ross transacted 20.3k sh — Chief Financial Officer ~$62k
    2026-03-27INSIDERVirnich Daniel transacted 670.6k sh — Chief Executive Officer
    2026-03-27INSIDERVirnich Daniel transacted 98.5k sh — Chief Executive Officer ~$302k
    2026-03-27INSIDERChernett Jorey bought 27.4k sh — 10% owner ~$81k
    Showing the 40 most recent of 51 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage